These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3257993)

  • 61. Increased T cell cytotoxicity by Betathine-induced upregulation of TNFalpha.
    Dunn TM; Wormsley S; Taub FE; Pontzer CH
    Int J Immunopharmacol; 2000 Mar; 22(3):213-27. PubMed ID: 10685004
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Establishment of rat-mouse T cell hybridomas that constitutively produce a soluble factor that is needed for the generation of cytotoxic cells: biochemical and functional characterization.
    Uede T; Kohda H; Ibayashi Y; Kikuchi K
    J Immunol; 1985 Nov; 135(5):3252-7. PubMed ID: 3876381
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor.
    Young JD; Liu CC; Butler G; Cohn ZA; Galli SJ
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9175-9. PubMed ID: 3321069
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A novel addition to the T cell repertory. Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells.
    Kinkhabwala M; Sehajpal P; Skolnik E; Smith D; Sharma VK; Vlassara H; Cerami A; Suthanthiran M
    J Exp Med; 1990 Mar; 171(3):941-6. PubMed ID: 2307938
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Appearance of cytolytic granules upon induction of cytolytic activity in CTL-hybrids.
    Masson D; Corthésy P; Nabholz M; Tschopp J
    EMBO J; 1985 Oct; 4(10):2533-8. PubMed ID: 2414099
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cell lines cultured at high density are resistant to lysis by tumor necrosis factor and natural cytotoxic cells.
    Patek PQ; Lin Y; Case PG
    Proc Soc Exp Biol Med; 1989 Mar; 190(3):234-9. PubMed ID: 2784212
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immuno-deficiency acquired during carcinogenesis: a mechanism facilitating cancer development.
    Zang YH; Zhang SR; Chen LP; Dong ZY; Xia HZ; Sun DM; Yin L
    Chin Med J (Engl); 1987 Jun; 100(6):465-71. PubMed ID: 3115725
    [No Abstract]   [Full Text] [Related]  

  • 68. TNF susceptibility-related gene expression.
    Kinebuchi T; Nishimura H; Yoshida T
    Immunol Lett; 1991 Jan; 27(1):25-30. PubMed ID: 2019418
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tumor necrosis factor/cachectin as an effector of T cell-dependent immunopathology.
    Grau GE; Lambert PH; Vassalli P; Piguet PF
    Int Rev Exp Pathol; 1993; 34 Pt B():159-71. PubMed ID: 8458711
    [No Abstract]   [Full Text] [Related]  

  • 70. Cytolytic T-cell clones and hybridomas.
    von Boehmer H; Haas W
    Methods Enzymol; 1986; 132():467-77. PubMed ID: 3493416
    [No Abstract]   [Full Text] [Related]  

  • 71. In vivo lymphokine production in experimental autoimmune uveoretinitis.
    Charteris DG; Lightman SL
    Immunology; 1993 Mar; 78(3):387-92. PubMed ID: 8478022
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification and characterization of a membrane-bound cytotoxin of murine cytolytic lymphocytes that is related to tumor necrosis factor/cachectin.
    Liu CC; Detmers PA; Jiang SB; Young JD
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3286-90. PubMed ID: 2654942
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages.
    Shakhov AN; Collart MA; Vassalli P; Nedospasov SA; Jongeneel CV
    J Exp Med; 1990 Jan; 171(1):35-47. PubMed ID: 2104921
    [TBL] [Abstract][Full Text] [Related]  

  • 74. RNA processing is a limiting step for murine tumor necrosis factor beta expression in response to interleukin-2.
    Weil D; Brosset S; Dautry F
    Mol Cell Biol; 1990 Nov; 10(11):5865-75. PubMed ID: 1700275
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expression of the tumor necrosis factor locus is not necessary for the cytolytic activity of T lymphocytes.
    Jongeneel CV; Nedospasov SA; Plaetinck G; Naquet P; Cerottini JC
    J Immunol; 1988 Mar; 140(6):1916-22. PubMed ID: 3257993
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Expression of two distinct cytolytic mechanisms among murine CD4 subsets.
    Ju ST; Ruddle NH; Strack P; Dorf ME; DeKruyff RH
    J Immunol; 1990 Jan; 144(1):23-31. PubMed ID: 1967264
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lymphokine expression profile of resting and stimulated CD4+ CTL clones specific for the glycoprotein of vesicular stomatitis virus.
    Cao BN; Huneycutt BS; Gapud CP; Arceci RJ; Reiss CS
    Cell Immunol; 1993 Jan; 146(1):147-56. PubMed ID: 8381052
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. II. A novel CTL-produced cytotoxin that is antigenically distinct from tumor necrosis factor and alpha-lymphotoxin.
    Green LM; Reade JL; Ware CF; Devlin PE; Liang CM; Devlin JJ
    J Immunol; 1986 Dec; 137(11):3488-93. PubMed ID: 2431035
    [TBL] [Abstract][Full Text] [Related]  

  • 79. An anergic cytotoxic T lymphocyte clone exhibits granule exocytosis-mediated cytotoxicity.
    Kuwano K; Akashi A; Arai S
    Cell Immunol; 1998 May; 185(2):114-22. PubMed ID: 9636689
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.